Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pamplona
Clinical trial register · Spain

Clinical Trials in Pamplona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC44 AstraZeneca41 Novartis Pharmaceuticals22 AbbVie20 Fundacion Miguel Servet18 Clear sponsor filter
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Pamplona

41 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
750
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Seville, Valencia
2026-06-26
Active, closed
AstraZeneca
Phase 2
326
Barcelona, Jaén, L'Hospitalet de Llobregat, Majadahonda, Málaga, Pamplona, Salamanca, Valencia
2026-06-11
Recruiting
AstraZeneca
Phase 1/2
152
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona
2026-06-03
Recruiting
AstraZeneca
Phase 3
508
Barcelona, Madrid, Pamplona, Salamanca, Santander, Valencia
2026-02-23
Recruiting
AstraZeneca
Phase 3
2,130
Barcelona, Madrid, Pamplona, Santander, Santiago de Compostela, Valencia
2026-02-03
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón, Valencia
2025-11-24
Recruiting
AstraZeneca
Phase 1
72
Barcelona, Madrid, Pamplona, Salamanca, Valencia
2025-11-03
Recruiting
AstraZeneca
Phase 1/2
283
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santander, Valencia
2025-10-01
Recruiting
AstraZeneca
Phase 1/2
304
Barcelona, Pamplona
2025-03-27
Recruiting
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Recruiting
AstraZeneca
Phase 2
80
Barcelona, Madrid, Málaga, Pamplona, Santander, Valencia
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
A Coruña, Almería, Badalona, L'Hospitalet de Llobregat, Majadahonda, Málaga, Palma deMallorca, Pamplona
2025-03-03
Active, closed
AstraZeneca
Phase 2
194
A Coruña, Alcorcón, Barcelona, Madrid, Málaga, Pamplona, Santander, Santiago de Compostela
2024-08-27
Recruiting
AstraZeneca
Phase 3
1,018
Barcelona, El Palmar, Girona, Las Palmas de Gran Canaria, Madrid, Oviedo, Pamplona, Santander
2024-08-07
Recruiting
AstraZeneca
Phase 3
788
A Coruña, Barcelona, Cáceres, Granada, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2024-08-01
Recruiting
AstraZeneca
Phase 1/2
60
Pamplona
2024-03-12
Active, closed
AstraZeneca
Phase 2
142
Barakaldo, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Valencia, Zaragoza
2024-02-22
Recruiting
AstraZeneca
Phase 1/2
226
Badalona, Madrid, Pamplona, Salamanca
2023-12-05
Recruiting
AstraZeneca
Phase 1/2
564
Barcelona, Pamplona, Valencia
2023-12-05
Active, closed
AstraZeneca
Phase 3
760
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Santander
2023-12-04
Recruiting
AstraZeneca
Phase 3
625
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Pamplona, Santander
2023-11-23
Active, closed
AstraZeneca
Phase 3
142
Barcelona, Madrid, Pamplona, Seville
2023-08-16
Active, closed
AstraZeneca
Phase 3
111
Barcelona, Córdoba, Madrid, Pamplona
2023-06-27
Active, closed
AstraZeneca
Phase 2
294
Barcelona, Madrid, Pamplona
2023-04-24
Recruiting
AstraZeneca
Phase 3
3,527
Barcelona, Madrid, Majadahonda, Málaga, Ourense, Palma de Mallorca, Pamplona, Santander
2022-12-13
Active, closed
AstraZeneca
Phase 3
368
Barcelona, Madrid, Pamplona, Seville, Tomelloso
2022-11-10
Recruiting
AstraZeneca
Phase 2
454
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Seville
2022-09-06
Active, closed
AstraZeneca
Phase 2
194
Barcelona, Madrid, Málaga, Pamplona, Pozuelo de Alarcón
2022-08-11
Active, closed
AstraZeneca
Phase 2
126
Badalona, Barcelona, Madrid, Majadahonda, Pamplona
2021-12-10
Active, closed
AstraZeneca
Phase 3
148
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-10-28
Recruiting
AstraZeneca
Phase 1/2
460
Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona
2021-10-18
Active, closed
AstraZeneca
Phase 3
712
Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Pamplona, Seville
2021-08-05
Active, closed
AstraZeneca
Phase 3
893
Barcelona, Granada, Lleida, Madrid, Málaga, Pamplona, Santiago de Compostela
2021-05-10
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
102
Barcelona, Madrid, Pamplona, Seville
2020-12-30
Active, closed
AstraZeneca
Phase 3
640
Barcelona, Córdoba, Madrid, Pamplona, Santander, Zaragoza
2020-10-19
Active, closed
AstraZeneca
Phase 3
185
Badalona, Barcelona, Córdoba, Donostia / San Sebastian, Granada, Madrid, Pamplona, Valencia
2020-08-04
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Córdoba, Madrid, Pamplona, San Sebastián(Guipuzcoa)
2018-11-30
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Barcelona, Córdoba, Girona, Madrid, Pamplona, Valencia
2013-09-03
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/pamplona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Pamplona that also match the filters currently applied.

How many clinical trials are recruiting in Pamplona?

20 of the 41 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pamplona), 41 studies
PhaseStudiesRecruitingShare
Phase 323956.1%
Phase 29222%
Phase 1/28819.5%
Phase 1112.4%

Most active sponsors

Lead sponsors with the most studies (Pamplona)
Lead sponsorStudiesRecruiting
AstraZeneca4120
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.